Hims & Hers Health, Inc is a household & personal products business based in the US. HIMS shares (HIMS.US) are listed on the NYSE and all prices are listed in US Dollars. HIMS employs 158 staff and has a trailing 12-month revenue of around $132.1 million.
|Latest market close||$N/A|
|52-week range||$9.4 - $25.4|
|50-day moving average||$18.5794|
|200-day moving average||$13.0952|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|Revenue TTM||USD$132.1 million|
|Gross profit TTM||USD$44.6 million|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||USD$3 billion|
TTM: trailing 12 months
There are currently 2.6 million HIMS shares held short by investors – that's known as HIMS's "short interest". This figure is up from 0 last month.
There are a few different ways that this level of interest in shorting HIMS shares can be evaluated.
HIMS's "short interest ratio" (SIR) is the quantity of HIMS shares currently shorted divided by the average quantity of HIMS shares traded daily (recently around 2.9 million). HIMS's SIR currently stands at 0.91. In other words for every 100,000 HIMS shares traded daily on the market, roughly 910 shares are currently held short.
However HIMS's short interest can also be evaluated against the total number of HIMS shares, or, against the total number of tradable HIMS shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case HIMS's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 HIMS shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable HIMS shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against HIMS.
Find out more about how you can short HIMS stock.
We're not expecting HIMS to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, collagen protein, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. The company was incorporated in 2013 and is based in San Francisco, California.
Everything we know about the Briggs-and-Stratton Corporation IPO, plus information on how to buy in. Read more…
Private equity could be a way to maximize returns. Learn more here.Read more…
Prepare to revamp your asset allocation and explore new investment classes when you’re in your 30s.Read more…
You’ll soon be able to invest in one of the largest digital banking platforms in the US.
Everything we know about the Klarna IPO, plus information on how to buy in.
Everything we know about the NerdWallet IPO, plus information on how to buy in.
Everything we know about the Klaviyo IPO, plus information on how to buy in.
Everything we know about the Interior Logic Group Holdings LLC IPO, plus information on how to buy in.
Everything we know about the Billtrust IPO, plus information on how to buy in.
Everything we know about the Lamborghini IPO, plus information on how to buy in.
Everything we know about the Sharecare IPO, plus information on how to buy in.
Everything we know about the Stripe IPO, plus information on how to buy in.
Steps to owning and managing AT&T stocks, with 24-hour and historical pricing before you buy.
You must be logged in to post a comment.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.